Skip to main content
Erschienen in:

24.04.2018 | Original Article

Left atrial pressure pattern without a-wave in sinus rhythm after cardioversion affects the outcomes after catheter ablation for atrial fibrillation

verfasst von: Hideyuki Kishima, Takanao Mine, Satoshi Takahashi, Kenki Ashida, Masaharu Ishihara, Tohru Masuyama

Erschienen in: Heart and Vessels | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

The a-wave in left atrial pressure (LAP) is often not observed after cardioversion (CV). We hypothesized that repeated atrial fibrillation (AF) occurs in patients who do not show a-wave pattern after CV. We investigated the impact of “LAP pattern without a-wave” on the outcome after catheter ablation (CA) for AF. We studied 100 patients (64 males, age 66 ± 8 years, 42 with non-paroxysmal AF) who underwent CA for AF. Sustained- or induced-AF were terminated with internal CV, and LAP was measured during sinus rhythm (SR) after CV. LAP pattern without a-wave was defined as absence of a-wave (the “a-wave” was defined as a protruding part by 0.2 mmHg or more from the baseline) in LAP wave form. AF was terminated with CV in all patients. Recurrent AF was detected in 35/100 (35%) during the follow-up period (13.1 ± 7.8 month). Univariate analysis revealed higher prevalence of LAP pattern without a-wave (71 vs. 17%, P < 0.0001), larger left atrial volume, elevated E wave, and decreased deceleration time as significant variables. On multivariate analysis, LAP pattern without a-wave was only independently associated with recurrent AF (P = 0.0014, OR 9.865, 95% CI 2.327–54.861). Moreover, patients with LAP pattern without a-wave had a higher risk of recurrent AF than patients with a-wave (25/36 patients, 69 vs. 10/64 patients, 16%, log-rank P < 0.0001). Left atrial pressure pattern without a-wave in sinus rhythm after cardioversion could predict recurrence after catheter ablation for AF.
Literatur
1.
Zurück zum Zitat Friberg L, Tabrizi F, Englund A (2016) Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J 37:2478–2488CrossRef Friberg L, Tabrizi F, Englund A (2016) Catheter ablation for atrial fibrillation is associated with lower incidence of stroke and death: data from Swedish health registries. Eur Heart J 37:2478–2488CrossRef
2.
Zurück zum Zitat Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S (2010) Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review. J Cardiovasc Electrophysiol 21:1208–1216CrossRef Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S (2010) Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: a systematic review. J Cardiovasc Electrophysiol 21:1208–1216CrossRef
3.
Zurück zum Zitat Park JH, Pak HN, Lee S, Park HK, Seo JW, Chang BC (2013) The clinical significance of the atrial subendocardial smooth muscle layer and cardiac myofibroblasts in human atrial tissue with valvular atrial fibrillation. Cardiovasc Pathol 22:58–64CrossRef Park JH, Pak HN, Lee S, Park HK, Seo JW, Chang BC (2013) The clinical significance of the atrial subendocardial smooth muscle layer and cardiac myofibroblasts in human atrial tissue with valvular atrial fibrillation. Cardiovasc Pathol 22:58–64CrossRef
4.
Zurück zum Zitat Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870CrossRef Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ (2001) Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 285:2864–2870CrossRef
5.
Zurück zum Zitat Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 137:263–272CrossRef Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ (2010) Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the Euro heart survey on atrial fibrillation. Chest 137:263–272CrossRef
6.
Zurück zum Zitat Kishima H, Mine T, Takahashi S, Ashida K, Ishihara M, Masuyama T (2016) The impact of left atrial pressure on filtered P-wave duration in patients with atrial fibrillation. Heart Vessels 31:1848–1854CrossRef Kishima H, Mine T, Takahashi S, Ashida K, Ishihara M, Masuyama T (2016) The impact of left atrial pressure on filtered P-wave duration in patients with atrial fibrillation. Heart Vessels 31:1848–1854CrossRef
7.
Zurück zum Zitat Fatkin D, Kelly RP, Feneley MP (1994) Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23:961–969CrossRef Fatkin D, Kelly RP, Feneley MP (1994) Relations between left atrial appendage blood flow velocity, spontaneous echocardiographic contrast and thromboembolic risk in vivo. J Am Coll Cardiol 23:961–969CrossRef
8.
Zurück zum Zitat Kishima H, Mine T, Takahashi S, Ashida K, Ishihara M, Masuyama T (2016) The impact of elevated left atrial pressure in sinus rhythm after cardioversion on outcomes after catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 27:813–819CrossRef Kishima H, Mine T, Takahashi S, Ashida K, Ishihara M, Masuyama T (2016) The impact of elevated left atrial pressure in sinus rhythm after cardioversion on outcomes after catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol 27:813–819CrossRef
9.
Zurück zum Zitat Yoshida K, Ulfarsson M, Oral H, Crawford T, Good E, Jongnarangsin K, Bogun F, Pelosi F, Jalife J, Morady F, Chugh A (2011) Left atrial pressure and dominant frequency of atrial fibrillation in humans. Heart Rhythm 8:181–187CrossRef Yoshida K, Ulfarsson M, Oral H, Crawford T, Good E, Jongnarangsin K, Bogun F, Pelosi F, Jalife J, Morady F, Chugh A (2011) Left atrial pressure and dominant frequency of atrial fibrillation in humans. Heart Rhythm 8:181–187CrossRef
10.
Zurück zum Zitat Kume O, Teshima Y, Abe I, Ikebe Y, Oniki T, Kondo H, Saito S, Fukui A, Yufu K, Miura M, Shimada T, Takahashi N (2017) Role of atrial endothelial cells in the development of atrial fibrosis and fibrillation in response to pressure overload. Cardiovasc Pathol 27:18–25CrossRef Kume O, Teshima Y, Abe I, Ikebe Y, Oniki T, Kondo H, Saito S, Fukui A, Yufu K, Miura M, Shimada T, Takahashi N (2017) Role of atrial endothelial cells in the development of atrial fibrosis and fibrillation in response to pressure overload. Cardiovasc Pathol 27:18–25CrossRef
11.
Zurück zum Zitat Park J, Yang PS, Kim TH, Uhm JS, Kim JY, Joung B, Lee MH, Hwang C, Pak HN (2015) Low left atrial compliance contributes to the clinical recurrence of atrial fibrillation after catheter ablation in patients with structurally and functionally normal heart. PLoS ONE 10:e0143853CrossRef Park J, Yang PS, Kim TH, Uhm JS, Kim JY, Joung B, Lee MH, Hwang C, Pak HN (2015) Low left atrial compliance contributes to the clinical recurrence of atrial fibrillation after catheter ablation in patients with structurally and functionally normal heart. PLoS ONE 10:e0143853CrossRef
12.
Zurück zum Zitat Roy S, Couture P, Qizilbash B, Toupin F, Levesque S, Carrier M, Lambert J, Denault AY (2013) Hemodynamic pressure waveform analysis in predicting fluid responsiveness. J Cardiothorac Vasc Anesth 27:676–680CrossRef Roy S, Couture P, Qizilbash B, Toupin F, Levesque S, Carrier M, Lambert J, Denault AY (2013) Hemodynamic pressure waveform analysis in predicting fluid responsiveness. J Cardiothorac Vasc Anesth 27:676–680CrossRef
13.
Zurück zum Zitat Dogan A, Gedikli O, Ozaydin M, Acar G, Avsar A, Altinbas A (2009) Mitral annular velocity by Doppler tissue imaging for the evaluation of atrial stunning after cardioversion of atrial fibrillation. Int J Cardiovasc Imaging 25:113–120CrossRef Dogan A, Gedikli O, Ozaydin M, Acar G, Avsar A, Altinbas A (2009) Mitral annular velocity by Doppler tissue imaging for the evaluation of atrial stunning after cardioversion of atrial fibrillation. Int J Cardiovasc Imaging 25:113–120CrossRef
14.
Zurück zum Zitat Dagres N, Karatasakis G, Panou F, Athanassopoulos G, Maounis T, Tsougos E, Kourea K, Malakos I, Kremastinos DT, Cokkinos DV (2006) Pre-treatment with irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation. Eur Heart J 27:2062–2068CrossRef Dagres N, Karatasakis G, Panou F, Athanassopoulos G, Maounis T, Tsougos E, Kourea K, Malakos I, Kremastinos DT, Cokkinos DV (2006) Pre-treatment with irbesartan attenuates left atrial stunning after electrical cardioversion of atrial fibrillation. Eur Heart J 27:2062–2068CrossRef
15.
Zurück zum Zitat Khan IA (2003) Atrial stunning: determinants and cellular mechanisms. Am Heart J 145:787–794CrossRef Khan IA (2003) Atrial stunning: determinants and cellular mechanisms. Am Heart J 145:787–794CrossRef
16.
Zurück zum Zitat Zhang Q, Yip GW, Yu CM (2008) Approaching regional left atrial function by tissue Doppler velocity and strain imaging. Europace 10(Suppl 3):62–69 Zhang Q, Yip GW, Yu CM (2008) Approaching regional left atrial function by tissue Doppler velocity and strain imaging. Europace 10(Suppl 3):62–69
17.
Zurück zum Zitat Shapiro EP, Effron MB, Lima S, Ouyang P, Siu CO, Bush D (1988) Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol 62:1202–1207CrossRef Shapiro EP, Effron MB, Lima S, Ouyang P, Siu CO, Bush D (1988) Transient atrial dysfunction after conversion of chronic atrial fibrillation to sinus rhythm. Am J Cardiol 62:1202–1207CrossRef
18.
Zurück zum Zitat Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA, Mode Selection Trial Investigators (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937CrossRef Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, Lamas GA, Mode Selection Trial Investigators (2003) Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 107:2932–2937CrossRef
19.
Zurück zum Zitat Brooks AG, Stiles MK, Laborderie J, Lau DH, Kuklik P, Shipp NJ, Hsu LF, Sanders P (2010) Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm 7:835–846CrossRef Brooks AG, Stiles MK, Laborderie J, Lau DH, Kuklik P, Shipp NJ, Hsu LF, Sanders P (2010) Outcomes of long-standing persistent atrial fibrillation ablation: a systematic review. Heart Rhythm 7:835–846CrossRef
Metadaten
Titel
Left atrial pressure pattern without a-wave in sinus rhythm after cardioversion affects the outcomes after catheter ablation for atrial fibrillation
verfasst von
Hideyuki Kishima
Takanao Mine
Satoshi Takahashi
Kenki Ashida
Masaharu Ishihara
Tohru Masuyama
Publikationsdatum
24.04.2018
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 11/2018
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-018-1176-7

Kompaktes Leitlinien-Wissen Innere Medizin (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Kardiologie

Lohnt sich Blutdrucksenkung unter 120 mmHg?

Eine Metaanalyse von fünf klinischen Studien bestätigt: Eine intensive Blutdrucksenkung unter systolisch 120 mmHg geht mit einer geringeren Mortalität und weniger kardiovaskulären Ereignissen einher als eine Senkung unter 140 mmHg. Allerdings nimmt das Risiko für Nebenwirkungen bei intensiver Blutdrucksenkung deutlich zu.

Vorhofflimmern plus KHK: Die optimale antithrombotische Langzeittherapie

Antikoagulation allein oder in Kombination mit einem Plättchenhemmer – was ist bei Koexistenz von KHK und Vorhofflimmern die optimale antithrombotische Langzeittherapie? Eine neue Metaanalyse könnte bei der Entscheidung hilfreich sein.

Periprozeduraler Myokardschaden nach NSTEMI prognostisch bedeutsam

Erleiden NSTEMI-Patienten und -Patientinnen infolge einer PCI Myokardschädigungen mit oder ohne Infarkt, erhöht das die Gesamtmortalität und das Risiko für weitere schwere Herzereignisse. Dafür sprechen zumindest Daten aus zwei italienischen Zentren.

Blutung unter Antikoagulation: Nach maligner Ursache suchen!

Wenn ältere Menschen mit Vorhofflimmern unter oraler Antikoagulation eine Blutung erleiden, sollte die nicht vorschnell als iatrogene Komplikation eingeordnet werden: Die Blutung kann das erste Zeichen einer Krebserkrankung sein.

EKG Essentials: EKG befunden mit System (Link öffnet in neuem Fenster)

In diesem CME-Kurs können Sie Ihr Wissen zur EKG-Befundung anhand von zwölf Video-Tutorials auffrischen und 10 CME-Punkte sammeln.
Praxisnah, relevant und mit vielen Tipps & Tricks vom Profi.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.